Cryo Cell International Inc (CCEL) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, Cryo Cell International Inc (NYSE:CCEL) is held by 17 institutional firms.

• The percentage of Cryo Cell International owned by institutions changed from 12.5% in September 2025 to 12.5% in December 2025, marking a slight down trend.
• Quarterly data indicates a 0.49% shift in institutional share volume, and the annual owner count reflects a decrease of 19.05%.
• A review of institutional activity for Cryo Cell International shows 6 of 17 filers increasing their positions, while 2 reduced their stake, and 9 remained unchanged.
• The aggregate institutional position in Cryo Cell International now stands at 982.89K shares as of December 2025, after investors increased their holdings (up by 4.75K shares quarter on quarter which is down 48.40K shares year over year).
• HAMILTON LANE ADVISORS LLC continues to be the largest institutional holder of Cryo Cell International as of December 31, 2025, with a position of 409.73K shares, representing 5.19% of the company's outstanding stock.
• Among the most significant buyers of Cryo Cell International during December 2025 were CITADEL ADVISORS LLC (3.13K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.19K), BlackRock, Inc. (516), ROYAL BANK OF CANADA (105), UBS Group AG (82).
• Leading sellers of Cryo Cell International stock in December 2025 included GEODE CAPITAL MANAGEMENT, LLC (247), Tower Research Capital LLC (TRC) (20).
• The top 10 institutional holders of Cryo Cell International for the quarter ending December 2025 included HAMILTON LANE ADVISORS LLC (409.73K), SFI Advisors, LLC (165.30K), VANGUARD GROUP INC (150.99K), MassMutual Private Wealth & Trust, FSB (111.03K), GEODE CAPITAL MANAGEMENT, LLC (53.17K), NORTHERN TRUST CORP (28.72K), Cerity Partners LLC (19.56K), CITADEL ADVISORS LLC (14.53K), BlackRock, Inc. (12.87K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (12.25K).